Alzamend Neuro, Inc.ALZNNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank44
3Y CAGR-28.8%
5Y CAGR+0.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-28.8%/yr
vs +92.4%/yr prior
5Y CAGR
+0.1%/yr
Recent deceleration
Acceleration
-121.2pp
Decelerating
Percentile
P44
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $4.45M | -55.3% |
| 2024 | $9.94M | -33.2% |
| 2023 | $14.87M | +20.7% |
| 2022 | $12.32M | +148.8% |
| 2021 | $4.95M | +11.9% |
| 2020 | $4.42M | -11.7% |
| 2019 | $5.01M | +457.5% |
| 2018 | $898430.00 | -42.0% |
| 2017 | $1.55M | +2128.7% |
| 2016 | $69456.00 | - |